Known as Breast Circulating Methylation Assay (BCMA), the new blood test looks for tumour DNA released into the bloodstream ...

Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

Potentially any day now, the US Food and Drug Administration (FDA) will rule on a request which – if granted – will boost ...

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment products and ...

British scientists have developed a pioneering blood test to boost survival chances by quickly identifying breast cancer ...

Plus Therapeutics (PSTV)’ wholly-owned subsidiary CNSide Diagnostics has been granted lab licenses to provide the CNSide Cerebrospinal Fluid Tumor ...

Basel, 9 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE Mark for its cobas® BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...

Belararox has defined a new exploration strategy for upcoming diamond drilling at its Toro, Malambo and Tambo (TMT) project ...

DOE has awarded $11m to five US companies to design and licence HALEU transport packages, strengthening fuel infrastructure ...